Will 2024 be a year of regulatory renaissance? Viveka Roychowdhury Jan 2, 2024 2024 will thus be a year to rebuild trust in the CDSCO, with more stringent regulations, coupled with stricter implementation of…
India inspects drug factories as Gambia controversy lingers Reuters Dec 28, 2022 India is known as the “pharmacy of the world” and its pharma exports have more than doubled over the past decade to $24.5 billion…
India says samples taken from pharma firm linked to Gambia deaths meet required standards Reuters Dec 16, 2022 Indian health authorities announced a production halt at Maiden Pharma's factory in Sonepat in northern India in October after a…
Need for introspection beyond brand-building Viveka Roychowdhury Nov 1, 2022 Because laws are only as good as their enforcement
Indonesia bans cough syrup material linked to Gambia child deaths Reuters Oct 17, 2022 The World Health Organization (WHO) has said it found "unacceptable" levels of the ingredients, which can be toxic, in four Maiden…
CDSCO requests WHO to share its report on establishment of causal relation to death with Maiden… Press Information Bureau Oct 7, 2022 The WHO, on 29th September, 2022, had informed DCGI, that it is currently providing technical assistance and advice to Gambia,…
Maiden Pharma trying to find out about cough syrup-linked deaths in Gambia Reuters Oct 6, 2022 Tedros Adhanom Ghebreyesus, Director-General, WHO, last week told reporters the UN agency was investigating 66 deaths from acute…